UPDATE : Friday, September 21, 2018
상단여백
Procedures of genetic therapy Invossa exceed 1,000 cases by So Jae-hyeon 2018-05-31 14:14
Korean biosimilar makers tap into Japan by So Jae-hyeon 2018-05-30 15:41
Will biotech stocks rebound on listings in H2? by So Jae-hyeon 2018-05-30 11:33
Pfizer strives to save blockbuster anti-smoking drug by So Jae-hyeon 2018-05-28 11:57
Korean drugmakers raid ‘pharmerging’ markets by So Jae-hyeon 2018-05-25 14:32
라인
Local drugs to challenge Parkinson’s disease treatment Azilect by So Jae-hyeon 2018-05-23 15:42
Dongwha, Hugel boost Q1 earnings under new CEO by So Jae-hyeon 2018-05-17 11:45
Hanyang rheumatic disease hospital to focus on intractable diseases by So Jae-hyeon 2018-05-16 15:21
Warm inter-Korean relations may benefit GC Pharma, Dong-A ST by So Jae-hyeon 2018-05-15 15:50
‘FDA is adapting to fast-changing digital healthcare’ by So Jae-hyeon 2018-05-11 16:22
라인
‘Open innovation a must in new drug development' by So Jae-hyeon 2018-05-10 16:05
How are Korean drugmakers faring in US? by So Jae-hyeon 2018-05-09 15:55
Hanmi wins FDA nod for arthritis treatment Hyalrheuma by So Jae-hyeon 2018-05-09 11:59
Boryung’s antihypertensive drug Kanarb tops output among new drugs by So Jae-hyeon 2018-05-08 16:05
Daewoong to seek US nod for liver drug Ursa this year by So Jae-hyeon 2018-05-08 14:37
라인
Korean pharma firms target rare diseases to enter US market by So Jae-hyeon 2018-04-30 16:42
Why is Medipost enhancing cord blood biz? by So Jae-hyeon 2018-04-26 16:44
Drugmakers compete to develop liver drugs by So Jae-hyeon 2018-04-20 14:18
Blockbuster Remicade losing out to Korean biosimilars in US by So Jae-hyeon 2018-04-19 15:39
Pharma sector embraces work-life balance by So Jae-hyeon 2018-04-19 14:25
여백
여백
여백
Back to Top